Related Experiment Video
Updated: Oct 23, 2025

17:12
Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS
Published on: December 20, 2010
15.7K
Using data mining technology to explore homocysteine at low levels.
Fei-Ching Tseng1, Tin-Chung Huang2
1The Lianan Wellness Center of the Lianan Preventative Medicine Institution, Songshan District, Taipei City.
Medicine
|August 20, 2021
Summary
Low homocysteine levels may indicate poor health, challenging the notion that only high levels are harmful. This study suggests homocysteine levels can be a key health management indicator.
Area of Science:
- Biochemistry
- Clinical Medicine
- Public Health
Background:
- High homocysteine levels are established cardiovascular disease risk factors.
- The health implications of low homocysteine levels remain under-researched.
- Acquiring healthy subject data for homocysteine studies presents challenges.
Purpose of the Study:
- To investigate the causal link between serum homocysteine levels and health status.
- To explore the relationship between homocysteine levels and lifestyle factors, especially low levels.
- To present a systematic platform for homocysteine data collection and analysis.
Main Methods:
- Cross-sectional analysis of 5864 health examination clients in Taipei, Taiwan (2017).
- Exclusion of personal identifying information.
- Statistical analysis using SPSS, including chi-square, t test, MANOVA, and logistic regression.
Main Results:
- Longer working hours (>12h/day) correlated with higher homocysteine levels (P < .001).
- Lower serum homocysteine levels (7.9 vs 8.6 μmol/L) were associated with poor sleep quality (P = .003).
- Subjects perceiving poor health status had lower homocysteine levels (≤6.3 μmol/L).
Conclusions:
- Homocysteine levels can serve as an effective health management indicator.
- A normal homocysteine level should be considered above 6.3 μmol/L.
- Fluctuations in homocysteine levels can provide insights into an individual's physical status.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
267
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
267
Therapeutic Drug Monitoring: Drug Analysis Methods
32
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
32

